![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 5 of 5. This is the beginning of the thread.
Posted by Juanantoniod on August 23, 2003, at 22:37:14
Has anyone heard anything new about Cymbalta's release?
Posted by Ame Sans Vie on August 23, 2003, at 23:35:24
In reply to Any news on Cymbalta?, posted by Juanantoniod on August 23, 2003, at 22:37:14
I heard something about it maybe being available the fourth quarter of 2003, but that may just be hearsay.
Posted by Juanantoniod on August 24, 2003, at 0:41:27
In reply to Re: Any news on Cymbalta? » Juanantoniod, posted by Ame Sans Vie on August 23, 2003, at 23:35:24
Thanks, Ame!
> I heard something about it maybe being available the fourth quarter of 2003, but that may just be hearsay.
Posted by River1924 on September 4, 2003, at 14:14:49
In reply to Re: Any news on Cymbalta? » Ame Sans Vie, posted by Juanantoniod on August 24, 2003, at 0:41:27
The Wall Street Journal said that Eli Lilly and Co has been asked by the FDA for additional clinical trials in the last few days and will be approved "pending additional satisfactory data how duloxetine is metabolized." Clinical trials are time consuming. Immediately the company's share price fell.
It is a bit confusing because duloxetine has been submitted to the FDA for two uses: depression and stress incontinence. The additional trials were requested for the stress incontinence application only. Since the the same chemical is used in both, "Lilly itself said it isn't certain [if the FDA requires more trials for both uses/applications] and has asked the FDA to clarify the issue."
Posted by juanantoniod on September 4, 2003, at 14:28:28
In reply to Re: Any news on Cymbalta? » Juanantoniod, posted by River1924 on September 4, 2003, at 14:14:49
That's an interesting development. Thanks for keeping us posted, River.
Antonio
> The Wall Street Journal said that Eli Lilly and Co has been asked by the FDA for additional clinical trials in the last few days and will be approved "pending additional satisfactory data how duloxetine is metabolized." Clinical trials are time consuming. Immediately the company's share price fell.
>
> It is a bit confusing because duloxetine has been submitted to the FDA for two uses: depression and stress incontinence. The additional trials were requested for the stress incontinence application only. Since the the same chemical is used in both, "Lilly itself said it isn't certain [if the FDA requires more trials for both uses/applications] and has asked the FDA to clarify the issue."
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.